Reading this on a mobile device? Try our optimized mobile version here:

February 14, 2013
Sign upForwardArchive
News for the PBM Industry

  Featured Stories 
  • Reps urge Postal Service to protect home delivery of prescription drugs
    The U.S. Postal Service must ensure that people who receive prescription drugs through the mail are not harmed by proposed cutbacks, 88 House members wrote in a letter to the postmaster general. "Consumers count on getting their prescriptions at the right time and often can't wait an additional two days, or even three days in the case of federal holidays that fall on a Monday," said PCMA President and CEO Mark Merritt, who noted that one in six mail-service prescriptions are delivered on a Saturday. The Hill/Healthwatch blog (2/13), Drug Store News (2/13) LinkedInFacebookTwitterEmail this Story
  Legislative & Regulatory News 
  • IOM: Tracking system needed to curb sales of fake drugs
    The Institute of Medicine has called for a national drug-tracking system following an FDA warning on counterfeit Avastin. Such a system might utilize barcodes or electronic tags to confirm the authenticity of a medication and the ingredients used during its production, an expert said. FDA Commissioner Dr. Margaret Hamburg lauded the report. CBS News/The Associated Press (2/13) LinkedInFacebookTwitterEmail this Story
  • Other News
  Drug Industry Spotlight 
  • Prescription drug costs rise 3.6%
    Figures from the Bureau of Economic Analysis show that prescription drug costs increased 3.6% last year, rising faster than inflation and other health care costs. Prices of branded treatments are driving the increase and offsetting rising use of generic drugs. USA Today (2/13) LinkedInFacebookTwitterEmail this Story
  • Drug industry pushes back against rebates for dual eligibles
    The Obama administration intends to require drugmakers to give rebates to some 10 million people who qualify for both Medicare and Medicaid and subscribe to the Medicare Part D program. The move could reduce spending by $137 billion, according to Congressional Budget Office estimates, but the drug industry says it would cut money available for research and development. Reuters (2/13) LinkedInFacebookTwitterEmail this Story
Mistakes are part of the dues that one pays for a full life."
--Sophia Loren,
Italian actress


Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Contact PCMA
Charles Cote
Assistant Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information